---
$id: https://graph.org.ai/products/commodity/51131703
$type: Product
source: UNSPSC
code: "51131703"
title: "Streptokinase"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Streptokinase

**UNSPSC Code**: 51131703
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme produced by hemolytic streptococci and which hydrolyzes amide linkages and serves as an activator of plasminogen, and is thus used in thrombolytic therapy, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X1OXL3SNU, chemically known as 4-cyclohexylpyrrolidine-2-carboxylic acid but generally known as streptokinase, which bears US NIH Compound Identifier 9815560. European Medicines Agency schedules Streptokinase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04589MIG. The term STREPTOKINASE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3.) Most nations schedule streptokinase under HS 35079090 and SITC 51691. As of Q4 2014, STREPTOKINASE remains the US FDA Preferred Term for this commodity. SMILES: C1CCC(CC1)C2CC(NC2)C(=O)O.

